Skip to main content
TERA SCIENCE Co.,LTD logo

TERA SCIENCE Co.,LTD — Investor Relations & Filings

Ticker · 073640 ISIN · KR7073640005 KO Manufacturing
Filings indexed 551 across all filing types
Latest filing 2026-04-09 Regulatory Filings
Country KR South Korea
Listing KO 073640

About TERA SCIENCE Co.,LTD

http://tera-science.com/en/

TERA SCIENCE Co., Ltd. is a diversified technology company that has evolved from its foundational business of manufacturing hydraulic fittings and high-pressure components. The company now focuses on high-growth sectors through several key divisions. Its Future Materials business, via subsidiary Tera Technos, develops and manufactures advanced materials for secondary batteries, specializing in high-capacity silicon-based (SiOx) cathodes for lithium-ion applications. In the biotechnology field, TERA SCIENCE is engaged in cancer immunotherapy and vaccine development through a strategic investment in Oncopep. The company also operates in the renewable energy sector, providing solar and wind power solutions, and is expanding into environmental waste management technologies. The original parts and materials division continues to supply precision components.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유형자산양도결정)
Regulatory Filings Classification · 65% confidence The document is a Korean regulatory announcement (Major Event Report) of a decision to transfer tangible assets (asset sale) and includes a correction (“정정신고”). It is not an annual, interim, earnings, or management report; nor does it announce board changes, dividends, share issues, M&A, or legal proceedings. There is no category for asset sale transactions, so this falls under the general “Regulatory Filings” fallback category.
2026-04-09 Korean
주요사항보고서(유형자산양도결정)
Regulatory Filings Classification · 80% confidence The document is a Korean ‘주요사항보고서’ (material event report) filed with the Financial Services Commission and Korea Exchange under the Capital Markets Act for disclosure of a tangible asset transfer decision. It is a statutory disclosure of a corporate action rather than a full financial report, earnings release, management change, share issuance, or M&A proposal. No specific category fits asset disposals, so it falls under the general regulatory announcement/fallback category.
2026-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a summary of the resolutions and their voting outcomes from a regular shareholders’ meeting held on 2026-03-30, listing agenda items, approval results, vote percentages, and related details. This matches the “Declaration of Voting Results & Voting Rights Announcements” category (vote results announcement).
2026-03-30 Korean
[기재정정]주요사항보고서(타법인주식및출자증권양도결정)
Regulatory Filings Classification · 72% confidence The document is a Korean ‘정정신고’ (correction notice) for a previously filed 주요사항보고서 (Major Matters Report) concerning the decision to transfer shares/securities of another entity. This is a regulatory disclosure correction rather than an annual or interim financial report, earnings release, board change, or proxy statement. It does not fit into the specific categories like Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS), so it falls into the fallback Regulatory Filings category.
2026-03-26 Korean
[기재정정]타법인주식및출자증권처분결정
Capital/Financing Update Classification · 65% confidence The document is a corporate announcement detailing the decision to dispose of equity securities (shares of another company) to raise operating funds. It provides specifics on the number of shares to be sold, expected sale date, board resolution date, and related financial ratios. This is not a share issue or buyback of the company’s own stock (so not SHA or POS), nor is it an earnings release, AGM material, or regulatory form submission. The sale to secure operating cash qualifies as a capital/financing update.
2026-03-26 Korean
[기재정정]타법인주식및출자증권처분결정(자율공시)
Regulatory Filings Classification · 62% confidence The document is a Korean voluntary disclosure (“자율공시”) titled ‘타법인 주식 및 출자증권 처분결정’, detailing the company’s decision to dispose equity interests in another entity. It is not reporting financial results (ER/IR/MDA), not an AGM or proxy material, not a share issue or buyback of its own shares, nor a regulatory/legal proceeding. It is a specific regulatory disclosure to the stock exchange that does not fit specialized categories like capital raise (CAP) or major shareholding thresholds (MRQ). Therefore it falls into the general Regulatory Filings category (RNS).
2026-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.